Quick Answer
Revolution Medicines, Inc. reported Total Revenue of $0.00 for fiscal year 2025.
Revolution Medicines, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $0.00 | — |
| 2024 | $0.00 | -100.0% |
| 2023 | $11.58M | -67.3% |
| 2022 | $35.38M | +20.4% |
| 2021 | $29.39M | -31.6% |
| 2020 | $42.98M | -14.1% |
| 2019 | $50.04M | +148.2% |
| 2018 | $20.16M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2024 | $0.00 | — | — |
| June 30, 2024 | $0.00 | -100.0% | — |
| March 31, 2024 | $0.00 | -100.0% | — |
| September 30, 2023 | $0.00 | -100.0% | -100.0% |
| June 30, 2023 | $3.82M | -58.1% | -45.5% |
| March 31, 2023 | $7.01M | -7.4% | +109.0% |
| September 30, 2022 | $3.36M | +204.8% | -63.2% |
| June 30, 2022 | $9.12M | +4.8% | +20.3% |
- Over the 2018–2025 period, Revolution Medicines, Inc.’s total revenue has declined by 100.0% (from $20.16 million to $0.00).
- The most recent figure is from Revolution Medicines, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: